The blockade of type I IFNs and TNF-α retained the frequency and suppressive activity of tumor-infiltrating MDSCs and impaired the therapeutic efficacy of anti-PD-1 treatment in a CRC mouse model. This evidence concerns the gene TNF and neoplasm.